Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger A Barker

Showing results (21-30 of 502) with videos related to

Pageof 51
Sort By:
Cold Spring Harbor Perspectives in Medicine|August 26, 2025
Addendum to Dopamine Cell-Based Replacement TherapiesSaeed Kayhanian, Roger A Barker
Cell Stem Cell|February 2, 2024
Sham surgery for the trialing of cell-based therapies to the CNS may not be necessaryViviane Tabar, Roger A Barker
Journal of Huntington'S Disease|September 4, 2015
Rating Apathy in Huntington’s Disease: Patients and Companions AgreeSarah Mason, Roger A Barker
Regenerative Medicine|September 8, 2012
What is the most promising treatment for Parkinson's disease: genes, cells, growth factors or none of the above?Gemma Cummins, Roger A Barker
Journal of Neurology|March 22, 2015
Progress in Huntington's disease: the search for markers of disease onset and progressionSarah Mason, Roger A Barker
Journal of Parkinson'S Disease|November 25, 2025
Clinical trial highlights: Dopamine cell-replacement therapiesSaeed Kayhanian, Roger A Barker
Brain : a Journal of Neurology|January 27, 2024
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's diseaseAnders Björklund, Roger A Barker
Nature Biomedical Engineering|January 12, 2023
Challenges in the clinical advancement of cell therapies for Parkinson's diseaseSophie Skidmore, Roger A Barker
Journal of Neurology|March 12, 2004
The future challenges in Parkinson's diseaseRoger A Barker, Thomas Foltynie
Brain : a Journal of Neurology|September 3, 2025
Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown?Roger A Barker, Malin Parmar
Pageof 51

Showing results (21-30 of 502) with videos related to

Sort By:
Pageof 51
Cold Spring Harbor Perspectives in Medicine|August 26, 2025
Addendum to Dopamine Cell-Based Replacement TherapiesSaeed Kayhanian, Roger A Barker
Cell Stem Cell|February 2, 2024
Sham surgery for the trialing of cell-based therapies to the CNS may not be necessaryViviane Tabar, Roger A Barker
Journal of Huntington'S Disease|September 4, 2015
Rating Apathy in Huntington’s Disease: Patients and Companions AgreeSarah Mason, Roger A Barker
Regenerative Medicine|September 8, 2012
What is the most promising treatment for Parkinson's disease: genes, cells, growth factors or none of the above?Gemma Cummins, Roger A Barker
Journal of Neurology|March 22, 2015
Progress in Huntington's disease: the search for markers of disease onset and progressionSarah Mason, Roger A Barker
Journal of Parkinson'S Disease|November 25, 2025
Clinical trial highlights: Dopamine cell-replacement therapiesSaeed Kayhanian, Roger A Barker
Brain : a Journal of Neurology|January 27, 2024
The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson's diseaseAnders Björklund, Roger A Barker
Nature Biomedical Engineering|January 12, 2023
Challenges in the clinical advancement of cell therapies for Parkinson's diseaseSophie Skidmore, Roger A Barker
Journal of Neurology|March 12, 2004
The future challenges in Parkinson's diseaseRoger A Barker, Thomas Foltynie
Brain : a Journal of Neurology|September 3, 2025
Stem cell-derived dopamine cell therapies for Parkinson's disease: what have the first trials shown?Roger A Barker, Malin Parmar
Pageof 51